세계의 특수 효소 시장 : 유형별, 형태별, 유래별, 용도별, 지역별 예측(-2029년)

Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029

US $ 4,950 ￦ 6,907,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,279,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,372,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,954,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 특수 효소 시장 규모는 2024년에 61억 달러로 추정되고, 2029년에는 92억 달러에 이를 것으로 예측되고 있으며, 예측기간 중 CAGR은 금액 기준으로 8.5%가 될 것으로 보입니다.

생체분자에서 복잡한 당 사슬을 절단하는 능력은 특이성이 높은 진단 도구의 개발에 엄청난 잠재력을 가지고 있습니다. 예를 들어, 탄수화물 분해 효소는 병원체의 특이적인 당쇄 서명을 표적화할 수 있어 감염의 신속하고 정확한 확인을 가능하게 합니다. 또한 특정 질병과 관련된 특이적인 당 사슬 마커를 분석하여보다 조기 및 정확한 진단을 도울 수 있습니다. 맞춤형 의료에 대한 주목이 높아지는 가운데, 탄수화물 분해 효소는 개인의 요구에 부응하는 진단법의 개발에 있어서 독자적인 강점을 발휘해, 진단 검사의 장래에 있어서 그 존재감을 확고하게 하고 있습니다.

조사 범위
조사 대상년도	2024-2029년
기준년	2023년
예측 기간	2024-2029년
검토 단위	금액(달러)
부문별	유형별, 형태별, 유래별, 용도별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 남미 및 기타 지역

미생물은 특히 연구·바이오테크놀러지에 있어서 다양한 용도에 이상적인 자질을 가지고 있기 때문에 특수 효소 시장의 유래 카테고리로 톱에 군림하고 있습니다. 박테리아와 곰팡이와 같은 미생물은 제어된 환경에서 쉽게 배양할 수 있어 대량의 효소를 확장 가능하고 비용 효율적으로 생산할 수 있습니다. 이것은 실험에 안정한 효소 공급이 필요한 연구에 매우 중요합니다. 미생물의 방대한 유전적 다양성은 매우 특이적인 기능을 가진 효소의 보고입니다. 과학자들은 이러한 효소를 활용하여 연구 및 생명 공학에서 필수적인 놀라운 정확도로 생체 분자를 조작 할 수 있습니다. 예를 들어, 미생물 효소는 DNA의 특정 부분을 선택적으로 절단하는데 사용될 수 있으며, 새로운 치료법 및 치료법의 창조에 필수적인 유전자 편집 기술을 용이하게 합니다. 게다가, 미생물은 유전자 재조합을 통해 새로운 특성을 가진 효소를 생산할 수 있어 연구 활동의 가능성을 더욱 넓힐 수 있습니다. 이러한 타의 추종을 불허하는 다양성과 적응성을 통해 미생물 유래의 효소는 연구 및 생명 공학 분야에서 특수 효소 시장의 주요 유래로 확고한 지위를 구축하고 있습니다.

유럽은 확립된 건강 관리 인프라를 자랑하며 특수 효소 산업에 대한 정부의 지원도 강력합니다. 이 때문에 특수효소를 이용한 치료를 포함한 혁신적인 치료에 대한 수요가 높아지고 있습니다. 유럽에서는 노화가 진행되고 있으며 만성 질환에 대한 효소 기반 치료 시장이 형성되고 있습니다. 게다가 지속가능한 실천에 대한 주목이 높아지고 있으며, 특수효소는 다양한 산업에서 기존의 화학촉매를 대체하는 보다 친환경적인 선택을 제공합니다. 또한 유럽의 효소 제조업체와 연구 기관 간의 협업이 시장 성장을 가속화하고 있습니다. 예를 들어 CORDIS-EU의 연구 결과에 따르면 2023년 12월에 시작된 EU 투자의 FuturEnzyme 프로젝트는 친환경 소비자를 위한 저비용 효소 개발을 목표로 하고 있습니다. 혁신적인 솔루션과 공동 작업을 통해 2025년 5월까지 효소의 발견과 최적화를 위해 약 67억 달러를 받을 예정입니다.

본 보고서에서는 세계의 특수효소 시장에 대해 조사했으며, 유형별, 형태별, 유래별, 용도별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 소개
• 거시경제지표
• 시장 역학

제6장 업계 동향

• 소개
• 공급망 분석
• 밸류체인 분석
• 무역 분석
• 기술 분석
• 가격 분석
• 에코시스템
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 특허 분석
• 2024-2025년의 주된 회의와 이벤트
• 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구매 기준
• 사례 연구
• 투자와 자금조달 시나리오

제7장 특수 효소 시장(유형별)

• 소개
• 탄수화물 분해 효소
• 프로테아제
• 리파제
• 폴리머라제와 뉴클레아제
• 기타

제8장 특수 효소 시장(형태별)

• 소개
• 액체
• 건조

제9장 특수 효소 시장(유래별)

• 소개
• 미생물
• 식물
• 동물

제10장 특수 효소 시장(용도별)

• 소개
• 의약품
• 연구와 생명공학
• 진단
• 생체촉매

제11장 특수 효소 시장(지역별)

• 소개
• 북미
• 유럽
• 아시아태평양
• 남미
• 기타 지역

제12장 경쟁 구도

• 개요
• 주요 진입기업의 전략/비책
• 수익 분석
• 시장 점유율 분석, 2023년
• 기업이치평가와 재무지표
• 브랜드/제품 비교
• 기업평가 매트릭스: 주요 진입기업, 2023년
• 기업평가 매트릭스: 스타트업/중소기업, 2023년
• 경쟁 시나리오와 동향

제13장 기업 프로파일

• 주요 진출기업
  • BRAIN BIOTECH AG
  • NOVOZYMES A/S
  • CODEXIS, INC.
  • SANOFI
  • MERCK KGAA
  • DYADIC INTERNATIONAL INC.
  • ADVANCED ENZYME TECHNOLOGIES
  • AMANO ENZYME INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • NEW ENGLAND BIOLABS
  • BBI SOLUTIONS
  • CREATIVE ENZYMES
  • BIOSEUTICA
  • SEKISUI DIAGNOSTICS
  • ANTOZYME BIOTECH PVT. LTD.
• 기타 기업
  • SI BIOZYME
  • AUMGENE BIOSCIENCES
  • ENZYME BIOSCIENCE
  • INFINITA BIOTECH PRIVATE LIMITED
  • BIOLAXI ENZYMES PVT. LTD.
  • FIDO PHARMA PVT. LTD.
  • 4BASEBIO
  • ANSEL BIOTECH
  • GENO TECHNOLOGY INC.
  • GUJARAT ENZYME

제14장 인접 시장과 관련 시장

제15장 부록

JHS

영문 목차

영문목차

According to MarketsandMarkets, the global Specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%, during the forecast period in terms of value. Their ability to cleave complex carbohydrates on biomolecules holds immense potential for developing highly specific diagnostic tools. For instance, carbohydrases can be used to target specific sugar signatures on pathogens, enabling rapid and accurate identification of infectious diseases. Additionally, they can be employed to analyze specific carbohydrate markers associated with certain illnesses, aiding in earlier and more precise diagnoses. As the focus on personalized medicine intensifies, carbohydrases offer a unique edge in developing diagnostics that cater to individual needs, solidifying their prominence in the future of diagnostic testing.

Scope of the Report
Years Considered for the Study	2024-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	By Type, By Source, By application, By Form and Region.
Regions covered	North America, Europe, Asia Pacific, South America, and Rest of the World

" By source, Microorganisms are estimated to dominate the market during the forecast period."

Microorganisms reign supreme in the source category of the specialty enzyme market due to their ideal qualities for various applications, particularly in research & biotechnology. Microbes like bacteria and fungi can be easily cultivated in controlled environments, allowing for scalable and cost-effective production of large enzyme quantities. This is crucial for research where consistent enzyme supplies are needed for experiments. The vast genetic diversity of microbes offers a treasure trove of enzymes with highly specific functions. Scientists can harness these enzymes to manipulate biomolecules with incredible precision, a necessity in research & biotechnology. For example, microbial enzymes can be used to selectively cut specific sections of DNA, facilitating gene editing techniques vital for creating new treatments and therapies. Furthermore, microbes can be genetically modified to create enzymes with novel properties, further expanding their potential in research endeavors. This unmatched versatility and adaptability solidify microorganism-derived enzymes as the leading source for the specialty enzyme market in research & biotechnology.

"Europe will significantly contribute towards market growth during the forecast period."

Europe boasts a well-established healthcare infrastructure with strong government support for specialty enzyme industries. This translates to a high demand for innovative medical treatments, including those that utilize specialty enzymes. Europe's aging population creates a market for enzyme-based therapies for chronic diseases. Additionally, there's a growing focus on sustainable practices, and specialty enzymes offer a more eco-friendly alternative to traditional chemical catalysts in various industries. Furthermore, collaborations between European enzyme manufacturers and research institutions are accelerating market growth. For instance, According to CORDIS - EU research results, starting in December 2023, the EU-funded FuturEnzyme project aims to develop low-cost enzymes for eco-friendly consumers. Through innovative solutions and collaborative efforts, it will receive approximately USD 6.7 billion for enzyme discovery and optimization until May 2025.

Break-up of Primaries:

By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%

By Designation: C-level-45%, D-level - 33%, and Others- 22%

By Region: North America - 15%, Europe - 20%, Asia Pacific - 40%, South America-12%, RoW - 13%,

Others include sales managers, territory managers, and product managers.

Leading players profiled in this report:

• BRAIN Biotech AG (Germany)
• Novozymes A/S (Denmark)
• Codexis, Inc. (US)
• Sanofi (France)
• Merck KGaA (Germany)
• Dyadic International Inc (US)
• Advanced Enzyme Technologies (India)
• Amano Enzyme Inc (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• New England Biolabs (US)
• BBI Solutions (UK)
• Creative Enzymes (US)
• Bioseutica (Netherland)
• SEKISUI Diagnostics (US)
• Antozyme Biotech Pvt Ltd (India)
• S.I. Biozyme (India)
• Aumgene Biosciences (India)
• enzymebiosciences (India)
• Infinita Biotech Private Limited (India)
• Biolaxi Corporation (India)
• Fido Pharma Pvt. Ltd. (India)
• 4basebio (UK)
• Ansel Biotech (India)
• Geno Technology Inc. (US)
• Gujarat Enzyme (India)

The study includes an in-depth competitive analysis of these key players in the specialty enzymes market with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the specialty enzymes market based on type, source, form, applications, and region. In terms of insights, this report has focused on various levels of analyses-the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global specialty enzymes market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall specialty enzymes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics), restraints (Lack of Harmonization in the Regulatory Framework), opportunities (Lack of Harmonization in the Regulatory Framework), and challenges (Lack of Harmonization in the Regulatory Framework) influencing the growth of the specialty enzymes market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the specialty enzymes market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the specialty enzymes market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the specialty enzymes market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), and Advanced Enzyme Technologies (India) among others in the specialty enzymes market strategies. The report also helps stakeholders understand the specialty enzymes market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • FIGURE 1 MARKET SEGMENTATION
  • 1.3.1 REGIONS COVERED
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
  • TABLE 1 USD EXCHANGE RATES, 2020-2023
• 1.6 UNIT CONSIDERED
• 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primary interviews
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY SPECIALTY ENZYME MANUFACTURER, DESIGNATION, AND REGION
• 2.2 FACTOR ANALYSIS
  • 2.2.1 INTRODUCTION
  • 2.2.2 DEMAND-SIDE ANALYSIS
  • FIGURE 4 KEY ECONOMIES BASED ON GDP, 2020-2023 (USD BILLION)
  • 2.2.3 SUPPLY-SIDE ANALYSIS
  • FIGURE 5 R&D EXPENDITURE ON BIOTECHNOLOGY, BY COUNTRY, 2023 (USD BILLION)
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
  • 2.3.2 APPROACH TWO (BASED ON GLOBAL MARKET)
• 2.4 DATA TRIANGULATION
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 LIMITATIONS & RISK ASSESSMENT
• 2.7 RECESSION IMPACT ANALYSIS
  • 2.7.1 MACRO-INDICATORS OF RECESSION
  • FIGURE 7 RECESSION INDICATORS
  • FIGURE 8 GLOBAL INFLATION RATE, 2013-2023
  • FIGURE 9 GLOBAL GROSS DOMESTIC PRODUCT, 2013-2023 (USD TRILLION)
  • FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON SPECIALTY ENZYMES MARKET
  • FIGURE 11 SPECIALTY ENZYMES MARKET: CURRENT FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

• TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2024 VS. 2029
• FIGURE 12 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 SPECIALTY ENZYMES MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 OPPORTUNITIES FOR PLAYERS IN SPECIALTY ENZYMES MARKET
  • FIGURE 16 ADVANCEMENTS IN DRUG DEVELOPMENT AND DISEASE DIAGNOSIS TO DRIVE DEMAND FOR SPECIALTY ENZYMES
• 4.2 SPECIALTY ENZYMES MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
  • FIGURE 17 US ACCOUNTED FOR LARGEST SHARE IN 2023
• 4.3 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE & KEY COUNTRY
  • FIGURE 18 MICROORGANISMS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARE IN 2024
• 4.4 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE
  • FIGURE 19 CARBOHYDRASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.5 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION
  • FIGURE 20 PHARMACEUTICALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INCREASE IN RETAIL SALES
  • FIGURE 21 RETAIL AND FOOD SERVICE SALES IN US, 2018-2023 (USD BILLION)
  • 5.2.2 GROWTH OPPORTUNITIES FOR MARKET IN ASIA PACIFIC AND SOUTH AMERICA
  • FIGURE 22 ANNUAL GDP GROWTH RATE IN ASIAN COUNTRIES, 2022
• 5.3 MARKET DYNAMICS
  • FIGURE 23 SPECIALTY ENZYMES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.3.1 DRIVERS
    • 5.3.1.1 Rise in demand for non-harmful biological catalysts in pharmaceuticals and diagnostics
    • 5.3.1.2 Supportive government policies and funding
    • 5.3.1.3 Advanced tools to optimize pharmaceutical production
  • FIGURE 24 EUROPE: PRODUCTION VALUE OF PHARMACEUTICALS, 2000-2022 (USD MILLION)
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 Lack of harmonization in regulatory framework
    • 5.3.2.2 High costs associated with specialty enzymes
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Rising significance of catalysts in pharmaceutical industry
    • 5.3.3.2 Technological innovations and wide industry scope
  • FIGURE 25 GROSS DOMESTIC EXPENDITURE ON R&D, 2017-2023 (USD BILLION)
    • 5.3.3.3 Development of enzymes with long shelf life
    • 5.3.3.4 Need for encapsulation to enhance shelf life of enzymes
    • 5.3.3.5 Utilization of plant biomass for production of specialty enzymes
  • 5.3.4 CHALLENGES
    • 5.3.4.1 High research and development costs
    • 5.3.4.2 Competition from alternative technologies or products

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 SUPPLY CHAIN ANALYSIS
  • FIGURE 26 SUPPLY CHAIN ANALYSIS
• 6.3 VALUE CHAIN ANALYSIS
  • FIGURE 27 SPECIALTY ENZYMES MARKET: VALUE CHAIN ANALYSIS
• 6.4 TRADE ANALYSIS
  • 6.4.1 EXPORT SCENARIO OF SPECIALTY ENZYMES
  • FIGURE 28 EXPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020-2023 (USD THOUSAND)
  • TABLE 3 TOP FIVE EXPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
  • 6.4.2 IMPORT SCENARIO OF SPECIALTY ENZYMES
  • FIGURE 29 IMPORT VALUE OF SPECIALTY ENZYMES FOR KEY COUNTRIES, 2020-2023 (USD THOUSAND)
  • TABLE 4 TOP FIVE IMPORTERS OF SPECIALTY ENZYMES (HS CODE 350790), 2023 (USD THOUSAND)
• 6.5 TECHNOLOGY ANALYSIS
  • 6.5.1 KEY TECHNOLOGIES
    • 6.5.1.1 Protein engineering for drug delivery
    • 6.5.1.2 Next-Generation Sequencing (NGS) for enzyme-based diagnostics
    • 6.5.1.3 Directed evolution of enzymes
  • 6.5.2 ADJACENT TECHNOLOGIES
    • 6.5.2.1 Food enzymes immobilization
• 6.6 PRICING ANALYSIS
  • 6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR KEY APPLICATIONS, 2022-2023 (USD/KG)
  • TABLE 5 AVERAGE SELLING PRICE OF KEY PLAYERS FOR KEY APPLICATIONS, 2020-2023 (USD/KG)
  • 6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
  • FIGURE 31 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020-2023 (USD/KG)
  • TABLE 6 SPECIALTY ENZYMES MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2020-2023 (USD/KG)
• 6.7 ECOSYSTEM
  • 6.7.1 SUPPLY SIDE
  • 6.7.2 DEMAND SIDE
  • FIGURE 32 SPECIALTY ENZYMES MARKET ECOSYSTEM
  • TABLE 7 SPECIALTY ENZYMES MARKET: ECOSYSTEM
• 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 33 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 6.9 PATENT ANALYSIS
  • FIGURE 34 LIST OF MAJOR PATENTS IN SPECIALTY ENZYMES MARKET
  • TABLE 8 LIST OF MAJOR PATENTS PUBLISHED, 2020-2024
• 6.10 KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 9 SPECIALTY ENZYMES MARKET: LIST OF KEY CONFERENCES & EVENTS, 2024-2025
• 6.11 REGULATORY LANDSCAPE
  • 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.11.2 REGULATIONS, BY REGION
    • 6.11.2.1 North America
      • 6.11.2.1.1 US
      • 6.11.2.1.2 Canada
    • 6.11.2.2 Europe
      • 6.11.2.2.1 European Union
    • 6.11.2.3 Asia Pacific
      • 6.11.2.3.1 China
      • 6.11.2.3.2 India
    • 6.11.2.4 South America
      • 6.11.2.4.1 Brazil
• 6.12 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 14 SPECIALTY ENZYMES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 6.12.1 INTENSITY OF COMPETITIVE RIVALRY
  • 6.12.2 BARGAINING POWER OF SUPPLIERS
  • 6.12.3 BARGAINING POWER OF BUYERS
  • 6.12.4 THREAT OF SUBSTITUTES
  • 6.12.5 THREAT OF NEW ENTRANTS
• 6.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF SPECIALTY ENZYMES FROM VARIOUS SOURCES
  • TABLE 15 INFLUENCE OF STAKEHOLDERS ON PURCHASE OF ENZYMES FROM VARIOUS SOURCES
  • 6.13.2 BUYING CRITERIA
  • TABLE 16 KEY BUYING CRITERIA FOR TOP FOUR SPECIALTY ENZYME APPLICATIONS
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE SPECIALTY ENZYME APPLICATIONS
• 6.14 CASE STUDIES
  • 6.14.1 BIOCATALYSTS ASSEMBLED MULTI-SKILLED PROJECT TEAM AND PRIORITIZED ON-SITE PRESENCE TO OVERCOME REMOTE WORKING CHALLENGES DURING COMMISSIONING PROCESS
  • 6.14.2 CODEXIS DEPLOYED ITS CODEEVOLVER PLATFORM TO DEVELOP HIGHLY EFFICIENT AND STEREOSPECIFIC KETOREDUCTASE ENZYMES
  • 6.14.3 THERMO FISHER SCIENTIFIC UTILIZED DIRECTED EVOLUTION TECHNIQUES TO ENGINEER NOVEL VARIANT OF PHI29 DNA POLYMERASE
• 6.15 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 37 INVESTMENT AND FUNDING SCENARIO

7 SPECIALTY ENZYMES MARKET, BY TYPE

• 7.1 INTRODUCTION
  • FIGURE 38 SPECIALTY ENZYMES MARKET, BY TYPE, 2024 VS. 2029
  • TABLE 17 SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 18 SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 19 SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (KILOTONS)
  • TABLE 20 SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (KILOTONS)
• 7.2 CARBOHYDRASES
  • 7.2.1 APPLICATIONS OF CARBOHYDRASES IN PHARMACEUTICAL, RESEARCH, AND BIOTECHNOLOGY SECTORS TO FUEL MARKET GROWTH
  • TABLE 21 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 22 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 23 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 24 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 25 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 26 CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 7.2.2 AMYLASES
  • TABLE 27 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 28 AMYLASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 7.2.3 CELLULASES
  • TABLE 29 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 30 CELLULASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 7.2.4 OTHER CARBOHYDRASES
  • TABLE 31 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 32 OTHER CARBOHYDRASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
• 7.3 PROTEASES
  • 7.3.1 INNOVATIVE PRODUCTS TAILORED FOR SPECIFIC APPLICATIONS TO DRIVE MARKET
  • TABLE 33 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 34 PROTEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 35 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 36 PROTEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
• 7.4 LIPASES
  • 7.4.1 USAGE OF LIPASES IN VARIOUS INDUSTRIAL AND SPECIALTY APPLICATIONS TO DRIVE MARKET
  • TABLE 37 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 38 LIPASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 39 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 40 LIPASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
• 7.5 POLYMERASES & NUCLEASES
  • 7.5.1 PIVOTAL ROLE OF POLYMERASES AND NUCLEASES IN ADVANCING NEXT-GENERATION SEQUENCING TECHNOLOGIES TO ACCELERATE MARKET GROWTH
  • TABLE 41 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 42 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 43 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 44 POLYMERASES & NUCLEASES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
• 7.6 OTHER ENZYMES
  • TABLE 45 USAGE OF OTHER ENZYMES IN VARIOUS APPLICATIONS
  • TABLE 46 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 47 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 48 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 49 OTHER ENZYMES: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)

8 SPECIALTY ENZYMES MARKET, BY FORM

• 8.1 INTRODUCTION
• 8.2 LIQUID
  • 8.2.1 NEED FOR REPLACING CHEMICAL CATALYSTS IN DIAGNOSIS OF VARIOUS CHRONIC DISEASES TO BOOST DEMAND FOR LIQUID ENZYMES
• 8.3 DRY
  • 8.3.1 ENHANCED STABILITY DURING STORAGE AND TRANSPORTATION, SIMPLIFIED ASSAY PROCEDURES, AND REDUCED RISK OF CONTAMINATION TO PROPEL MARKET GROWTH
  • FIGURE 39 FLOWCHART REPRESENTING PRODUCTION OF DRY ENZYMES

9 SPECIALTY ENZYMES MARKET, BY SOURCE

• 9.1 INTRODUCTION
  • FIGURE 40 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024 VS. 2029
  • TABLE 50 SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 51 SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
• 9.2 MICROORGANISMS
  • 9.2.1 NEED FOR ECONOMIC FEASIBILITY, HIGH YIELDS, CONSISTENCY, AND EASE OF PRODUCT OPTIMIZATION OF SPECIALTY ENZYMES TO BOOST MARKET
  • TABLE 52 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 53 MICROORGANISMS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
• 9.3 PLANTS
  • 9.3.1 ENZYMES DERIVED FROM PLANTS SPEED UP BIOCHEMICAL REACTIONS AND FUNCTION IN ACIDIC ENVIRONMENT
  • TABLE 54 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 55 PLANTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
• 9.4 ANIMALS
  • 9.4.1 ANIMAL-DERIVED ENZYMES FOCUS ON ENHANCING DRUG FORMULATION AND SYNTHESIS PROCESSES
  • TABLE 56 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 57 ANIMALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)

10 SPECIALTY ENZYMES MARKET, BY APPLICATION

• 10.1 INTRODUCTION
  • FIGURE 41 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024 VS. 2029
  • TABLE 58 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 59 SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
• 10.2 PHARMACEUTICALS
  • 10.2.1 INCREASING INCORPORATION OF ENZYMES IN THERAPIES TO DRIVE MARKET
  • TABLE 60 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 61 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 62 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 63 PHARMACEUTICALS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 10.3 RESEARCH & BIOTECHNOLOGY
  • 10.3.1 DROP IN DNA SEQUENCING COSTS AND RISE IN NEW SEQUENCING TECHNIQUES TO BOOST MARKET
  • TABLE 64 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 65 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 66 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 67 RESEARCH & BIOTECHNOLOGY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 10.4 DIAGNOSTICS
  • 10.4.1 SURGE IN INVESTMENTS AND RISING GERIATRIC POPULATION TO ACCELERATE MARKET GROWTH
  • TABLE 68 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 69 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 70 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 71 DIAGNOSTICS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 10.5 BIOCATALYSTS
  • 10.5.1 BIODEGRADATION OF PLASTICS BY MICROORGANISMS TO DRIVE DEMAND FOR ENZYMES
  • TABLE 72 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 73 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 74 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 75 BIOCATALYSTS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)

11 SPECIALTY ENZYMES MARKET, BY REGION

• 11.1 INTRODUCTION
  • FIGURE 42 ASIA PACIFIC TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
  • TABLE 76 SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 77 SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 78 SPECIALTY ENZYMES MARKET, BY REGION, 2020-2023 (KILOTONS)
  • TABLE 79 SPECIALTY ENZYMES MARKET, BY REGION, 2024-2029 (KILOTONS)
• 11.2 NORTH AMERICA
  • FIGURE 43 NORTH AMERICAN SPECIALTY ENZYMES MARKET SNAPSHOT
  • 11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
  • FIGURE 44 NORTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2017-2022
  • FIGURE 45 NORTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
  • TABLE 80 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 81 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 83 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 85 NORTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 87 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 89 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.2.2 US
    • 11.2.2.1 Increasing awareness among manufacturers regarding usage of enzymes for enhanced product quality to drive market
  • TABLE 90 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 91 US: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 92 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 93 US: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.2.3 CANADA
    • 11.2.3.1 Rise in cancer cases to lead to increased use of specialty enzymes in diagnostics
  • TABLE 94 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 95 CANADA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 96 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 97 CANADA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.2.4 MEXICO
    • 11.2.4.1 Need for detecting changes in substrate concentrations to boost market growth
  • TABLE 98 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 99 MEXICO: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 100 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 101 MEXICO: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 11.3 EUROPE
  • 11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
  • FIGURE 46 EUROPE: INFLATION RATES, BY KEY COUNTRY, 2017-2022
  • FIGURE 47 EUROPE: RECESSION IMPACT ANALYSIS, 2023
  • TABLE 102 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 103 EUROPE: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 104 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 105 EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 106 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 107 EUROPE: CARBOHYDRASES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 108 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 109 EUROPE: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 110 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 111 EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.3.2 ITALY
    • 11.3.2.1 Rise in production of pharmaceuticals to drive demand for specialty enzymes
  • TABLE 112 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 113 ITALY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 114 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 115 ITALY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.3 GERMANY
    • 11.3.3.1 Rapid technological advancements in pharmaceuticals sector to boost growth
  • TABLE 116 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 117 GERMANY: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 118 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 119 GERMANY: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.4 FRANCE
    • 11.3.4.1 Clinical developments impacting French biotechnology industry to increase usage of specialty enzymes
  • TABLE 120 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 121 FRANCE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 122 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 123 FRANCE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.5 SPAIN
    • 11.3.5.1 Spanish government's emphasis on developments in pharmaceutical industry to boost enzymes market
  • TABLE 124 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 125 SPAIN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 126 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 127 SPAIN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.6 UK
    • 11.3.6.1 Increased use of enzymes in drug cloning technique to spur demand
  • TABLE 128 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 129 UK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 130 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 131 UK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.7 DENMARK
    • 11.3.7.1 Growing export of enzymes to propel demand for specialty enzymes
  • TABLE 132 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 133 DENMARK: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 134 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 135 DENMARK: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.8 NETHERLANDS
    • 11.3.8.1 Sustainable lifestyle and demand for environment-friendly products to boost popularity of specialty enzymes
  • TABLE 136 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 137 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 138 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 139 NETHERLANDS: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.3.9 REST OF EUROPE
  • TABLE 140 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 141 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 142 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 143 REST OF EUROPE: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 11.4 ASIA PACIFIC
  • FIGURE 48 ASIA PACIFIC SPECIALTY ENZYMES MARKET SNAPSHOT
  • 11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
  • FIGURE 49 ASIA PACIFIC: INFLATION RATES, BY KEY COUNTRY, 2017-2022
  • FIGURE 50 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
  • TABLE 144 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: CARBOHYDRASES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.4.2 CHINA
    • 11.4.2.1 Rapid technical advancements to augment demand for specialty enzymes
  • TABLE 154 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 155 CHINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 156 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 157 CHINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.4.3 INDIA
    • 11.4.3.1 Rising demand for specialty enzymes in pharmaceutical industry to boost market
  • TABLE 158 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 159 INDIA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 160 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 161 INDIA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.4.4 JAPAN
    • 11.4.4.1 Growing biotechnology advancements in Japan to augment demand for specialty enzymes
  • TABLE 162 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 163 JAPAN: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 164 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 165 JAPAN: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Advancements in biotechnology, medical research, and biopharmaceuticals to boost usage of specialty enzymes
  • TABLE 166 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 167 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 168 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 169 SOUTH KOREA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.4.6 AUSTRALIA & NEW ZEALAND
    • 11.4.6.1 Favorable government regulations to increase biotechnology advancements and rise in popularity of specialty enzymes
  • TABLE 170 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 171 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 172 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 173 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.4.7 REST OF ASIA PACIFIC
  • TABLE 174 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 11.5 SOUTH AMERICA
  • 11.5.1 SOUTH AMERICA: RECESSION IMPACT
  • FIGURE 51 SOUTH AMERICA: INFLATION RATES, BY KEY COUNTRY, 2018-2022
  • FIGURE 52 SOUTH AMERICA: RECESSION IMPACT ANALYSIS, 2023
  • TABLE 178 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 179 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 180 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 181 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 182 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 183 SOUTH AMERICA: CARBOHYDRASES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 184 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 185 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 186 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 187 SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.5.2 BRAZIL
    • 11.5.2.1 Thriving pharmaceutical industry to drive demand for enzymes
  • TABLE 188 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 189 BRAZIL: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 190 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 191 BRAZIL: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.5.3 ARGENTINA
    • 11.5.3.1 Government support in pharmaceuticals and research and development to boost growth
  • TABLE 192 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 193 ARGENTINA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 194 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 195 ARGENTINA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.5.4 REST OF SOUTH AMERICA
  • TABLE 196 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 197 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 198 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 199 REST OF SOUTH AMERICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
• 11.6 REST OF THE WORLD
  • 11.6.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS
  • FIGURE 53 REST OF THE WORLD: INFLATION RATES, BY KEY COUNTRY, 2017-2022
  • FIGURE 54 REST OF THE WORLD: RECESSION IMPACT ANALYSIS, 2023
  • TABLE 200 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 201 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 202 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 203 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 204 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2020-2023 (USD MILLION)
  • TABLE 205 REST OF THE WORLD: CARBOHYDRASES MARKET, BY SUBTYPE, 2024-2029 (USD MILLION)
  • TABLE 206 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2020-2023 (USD MILLION)
  • TABLE 207 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 208 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 209 REST OF THE WORLD: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 11.6.2 AFRICA
    • 11.6.2.1 Rising demand for generic medicines to boost adoption of specialty enzymes in pharmaceutical industry
  • TABLE 210 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 211 AFRICA: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 212 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 213 AFRICA: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 11.6.3 MIDDLE EAST
    • 11.6.3.1 Government initiatives to promote biotechnological research and development to drive demand
  • TABLE 214 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 215 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 217 MIDDLE EAST: SPECIALTY ENZYMES MARKET, BY TYPE, 2024-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 218 OVERVIEW OF STRATEGIES ADOPTED BY KEY SPECIALTY ENZYME VENDORS
• 12.3 REVENUE ANALYSIS
  • FIGURE 55 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022 (USD MILLION)
• 12.4 MARKET SHARE ANALYSIS, 2023
  • FIGURE 56 SPECIALTY ENZYMES MARKET: DEGREE OF COMPETITION (CONSOLIDATED)
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • FIGURE 57 SPECIALTY ENZYMES MARKET: COMPANY VALUATION (USD BILLION)
  • FIGURE 58 EV/EBITDA OF KEY PLAYERS, 2023
• 12.6 BRAND/PRODUCT COMPARISON
  • FIGURE 59 SPECIALTY ENZYMES MARKET: BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • FIGURE 60 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  • FIGURE 61 SPECIALTY ENZYMES MARKET: COMPANY FOOTPRINT
  • TABLE 219 SPECIALTY ENZYMES MARKET: REGIONAL FOOTPRINT
  • TABLE 220 SPECIALTY ENZYMES MARKET: TYPE FOOTPRINT
  • TABLE 221 SPECIALTY ENZYMES MARKET: APPLICATION FOOTPRINT
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • FIGURE 62 SPECIALTY ENZYMES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
  • TABLE 222 SPECIALTY ENZYMES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
  • TABLE 223 SPECIALTY ENZYMES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• 12.9 COMPETITIVE SCENARIO AND TRENDS
  • 12.9.1 PRODUCT LAUNCHES
  • TABLE 224 SPECIALTY ENZYMES MARKET: PRODUCT LAUNCHES, DECEMBER 2021-FEBRUARY 2024
  • 12.9.2 DEALS
  • TABLE 225 SPECIALTY ENZYMES MARKET: DEALS, FEBRUARY 2019-APRIL 2024
  • 12.9.3 OTHERS
  • TABLE 226 SPECIALTY ENZYMES MARKET: OTHERS, MAY 2019-APRIL 2024

13 COMPANY PROFILES

• (Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 13.1 KEY PLAYERS
  • 13.1.1 BRAIN BIOTECH AG
  • TABLE 227 BRAIN BIOTECH AG: BUSINESS OVERVIEW
  • FIGURE 63 BRAIN BIOTECH AG: COMPANY SNAPSHOT
  • TABLE 228 BRAIN BIOTECH AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 229 BRAIN BIOTECH AG: OTHERS
  • 13.1.2 NOVOZYMES A/S
  • TABLE 230 NOVOZYMES A/S: BUSINESS OVERVIEW
  • FIGURE 64 NOVOZYMES A/S: COMPANY SNAPSHOT
  • TABLE 231 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 232 NOVOZYMES A/S: DEALS
  • TABLE 233 NOVOZYMES A/S: OTHERS
  • 13.1.3 CODEXIS, INC.
  • TABLE 234 CODEXIS, INC.: BUSINESS OVERVIEW
  • FIGURE 65 CODEXIS, INC.: COMPANY SNAPSHOT
  • TABLE 235 CODEXIS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 236 CODEXIS, INC.: PRODUCT LAUNCHES
  • TABLE 237 CODEXIS, INC.: DEALS
  • TABLE 238 CODEXIS, INC.: OTHERS
  • 13.1.4 SANOFI
  • TABLE 239 SANOFI: BUSINESS OVERVIEW
  • FIGURE 66 SANOFI: COMPANY SNAPSHOT
  • TABLE 240 SANOFI: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 241 SANOFI: DEALS
  • 13.1.5 MERCK KGAA
  • TABLE 242 MERCK KGAA: BUSINESS OVERVIEW
  • FIGURE 67 MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 243 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 244 MERCK KGAA: DEALS
  • TABLE 245 MERCK KGAA: OTHERS
  • 13.1.6 DYADIC INTERNATIONAL INC.
  • TABLE 246 DYADIC INTERNATIONAL INC.: BUSINESS OVERVIEW
  • FIGURE 68 DYADIC INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 247 DYADIC INTERNATIONAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 248 DYADIC INTERNATIONAL INC.: DEALS
  • 13.1.7 ADVANCED ENZYME TECHNOLOGIES
  • TABLE 249 ADVANCED ENZYME TECHNOLOGIES: BUSINESS OVERVIEW
  • FIGURE 69 ADVANCED ENZYME TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 250 ADVANCED ENZYME TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 251 ADVANCED ENZYME TECHNOLOGIES: DEALS
  • 13.1.8 AMANO ENZYME INC.
  • TABLE 252 AMANO ENZYME INC.: BUSINESS OVERVIEW
  • TABLE 253 AMANO ENZYME INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 254 AMANO ENZYME INC.: DEALS
  • TABLE 255 AMANO ENZYME INC.: OTHERS
  • 13.1.9 F. HOFFMANN-LA ROCHE LTD.
  • TABLE 256 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
  • FIGURE 70 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 257 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 258 F. HOFFMANN-LA ROCHE LTD.: DEALS
  • 13.1.10 NEW ENGLAND BIOLABS
  • TABLE 259 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
  • TABLE 260 NEW ENGLAND BIOLABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 261 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES
  • TABLE 262 NEW ENGLAND BIOLABS: DEALS
  • TABLE 263 NEW ENGLAND BIOLABS: OTHERS
  • 13.1.11 BBI SOLUTIONS
  • TABLE 264 BBI SOLUTIONS: BUSINESS OVERVIEW
  • TABLE 265 BBI SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 266 BBI SOLUTIONS: DEALS
  • 13.1.12 CREATIVE ENZYMES
  • TABLE 267 CREATIVE ENZYMES: BUSINESS OVERVIEW
  • TABLE 268 CREATIVE ENZYMES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.1.13 BIOSEUTICA
  • TABLE 269 BIOSEUTICA: BUSINESS OVERVIEW
  • TABLE 270 BIOSEUTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 271 BIOSEUTICA: DEALS
  • 13.1.14 SEKISUI DIAGNOSTICS
  • TABLE 272 SEKISUI DIAGNOSTICS: BUSINESS OVERVIEW
  • TABLE 273 SEKISUI DIAGNOSTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 SEKISUI DIAGNOSTICS: OTHERS
  • 13.1.15 ANTOZYME BIOTECH PVT. LTD.
  • TABLE 275 ANTOZYME BIOTECH PVT. LTD.: BUSINESS OVERVIEW
  • TABLE 276 ANTOZYME BIOTECH PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• 13.2 OTHER PLAYERS
  • 13.2.1 S.I. BIOZYME
  • TABLE 277 S.I. BIOZYME: BUSINESS OVERVIEW
  • TABLE 278 S.I. BIOZYME: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.2.2 AUMGENE BIOSCIENCES
  • TABLE 279 AUMGENE BIOSCIENCES: BUSINESS OVERVIEW
  • TABLE 280 AUMGENE BIOSCIENCES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.2.3 ENZYME BIOSCIENCE
  • TABLE 281 ENZYME BIOSCIENCE: BUSINESS OVERVIEW
  • TABLE 282 ENZYME BIOSCIENCE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.2.4 INFINITA BIOTECH PRIVATE LIMITED
  • TABLE 283 INFINITA BIOTECH PRIVATE LIMITED: BUSINESS OVERVIEW
  • TABLE 284 INFINITA BIOTECH PRIVATE LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.2.5 BIOLAXI ENZYMES PVT. LTD.
  • TABLE 285 BIOLAXI ENZYMES PVT. LTD.: BUSINESS OVERVIEW
  • TABLE 286 BIOLAXI ENZYMES PVT. LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 13.2.6 FIDO PHARMA PVT. LTD.
  • 13.2.7 4BASEBIO
  • 13.2.8 ANSEL BIOTECH
  • 13.2.9 GENO TECHNOLOGY INC.
  • 13.2.10 GUJARAT ENZYME
• *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 ADJACENT AND RELATED MARKETS

• 14.1 INTRODUCTION
  • TABLE 287 MARKETS ADJACENT TO SPECIALTY ENZYMES MARKET
• 14.2 LIMITATIONS
• 14.3 INDUSTRIAL ENZYMES MARKET
  • 14.3.1 MARKET DEFINITION
  • 14.3.2 MARKET OVERVIEW
  • TABLE 288 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2019-2022 (USD MILLION)
  • TABLE 289 INDUSTRIAL ENZYMES MARKET, BY APPLICATION, 2023-2028 (USD MILLION)
  • TABLE 290 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2019-2022 (USD MILLION)
  • TABLE 291 FOOD & BEVERAGES: INDUSTRIAL ENZYMES MARKET, BY SUB-APPLICATION, 2023-2028 (USD MILLION)
• 14.4 FOOD ENZYMES MARKET
  • 14.4.1 MARKET DEFINITION
  • 14.4.2 MARKET OVERVIEW
  • 14.4.3 FOOD ENZYMES MARKET, BY APPLICATION
  • TABLE 292 FOOD ENZYMES MARKET, BY TYPE, 2016-2020 (USD MILLION)
  • TABLE 293 FOOD ENZYMES MARKET, BY TYPE, 2021-2026 (USD MILLION)
  • 14.4.4 FOOD ENZYMES MARKET, BY REGION
  • TABLE 294 FOOD ENZYMES MARKET, BY REGION, 2016-2020 (USD MILLION)
  • TABLE 295 FOOD ENZYMES MARKET, BY REGION, 2021-2026 (USD MILLION)
• 14.5 FEED ENZYMES MARKET
  • 14.5.1 MARKET DEFINITION
  • 14.5.2 MARKET OVERVIEW
  • TABLE 296 FEED ENZYMES MARKET, BY REGION, 2016-2019 (USD MILLION)
  • TABLE 297 FEED ENZYMES MARKET, BY REGION, 2020-2025 (USD MILLION)

15 APPENDIX

• 15.1 DISCUSSION GUIDE
• 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.3 CUSTOMIZATION OPTIONS
• 15.4 RELATED REPORTS
• 15.5 AUTHOR DETAILS

관련자료